Pharmaceutical Information |
Drug Name |
Phenoxybenzamine hydrochloride |
Drug ID |
BADD_D01755 |
Description |
An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. |
Indications and Usage |
For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension. |
Marketing Status |
Prescription |
ATC Code |
C04AX02 |
DrugBank ID |
DB00925
|
KEGG ID |
D00507
|
MeSH ID |
D010643
|
PubChem ID |
5284441
|
TTD Drug ID |
D0X2DK
|
NDC Product Code |
76339-143; 49452-5214; 59212-001; 49884-038; 59651-298; 71292-123; 51927-0031; 47621-309; 14096-114; 76438-003; 60219-1502; 72969-057; 59981-023; 0054-0349; 58159-044; 66993-066; 58032-1014 |
Synonyms |
Phenoxybenzamine | Phenoxybenzamine Hydrochloride | Hydrochloride, Phenoxybenzamine | Dibenzyline | Dibenzylin | Dibenyline | Dibenylene | Dibenziran | Dibenzyran |
|
Chemical Information |
Molecular Formula |
C18H22ClNO.ClH |
CAS Registry Number |
63-92-3 |
SMILES |
CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|